Updated Jul 16, 2026
Satchi-Fainaro Ronit has filed 2 SEC Form 4 filings across 1 company in the last 90 days.

Ronit Satchi-Fainaro is an Israeli biomedical researcher whose name appears in association with Teva Pharmaceutical Industries Ltd in a SEC filing dated 2026-06-01. The filing excerpt does not specify her role, title, or tenure at Teva. Public records prior to 2024 identify Ronit Satchi-Fainaro as a professor and researcher specializing in nanomedicine and cancer therapy at Tel Aviv University, focusing on polymeric nanoparticles for targeted drug delivery. It is unclear whether the Teva reference pertains to the same individual or a different person with the same name. The current profile is based on the SEC context and is subject to confirmation.
| Role | Insider |
|---|---|
| Notability | 15/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-08 | TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | M — Option exercise | 14.5K | — |
Ronit Satchi-Fainaro is an Israeli biomedical researcher whose name appears in association with Teva Pharmaceutical Industries Ltd in a SEC filing dated 2026-06-01. The filing excerpt does not specify her role, title, or tenure at Teva. Public records prior to 2024 identify Ronit Satchi-Fainaro as a professor and researcher specializing in nanomedicine and cancer therapy at Tel…
2 primary Form 4 filings in the last 90 days, covering 1 company.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Satchi-Fainaro Ronit profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.